About Transdermal Diagnostics
Transdermal Diagnostics is developing the world’s first needle-free wearable for the continuous monitoring of health biomarkers; The first product targets people living with diabetes and the rapidly-growing population of those at risk of developing the disease
The latest technology designed to provide affordable and accessible solutions to global health challenges
Transdermal Diagnostics’ mission is to slow or prevent the progression of chronic diseases while supporting overall health and well-being. The company is developing the first non-invasive, needle-free wearable designed to help users manage their blood glucose levels and avoid harmful complications.
The core innovation uses reverse iontophoresis to extract glucose through natural transdermal pathways, specifically hair follicles. The patented technology features an array of miniaturized pixel sensing units that enable direct quantification and calibration-free monitoring. In this way, with multiple simultaneous measurements, the system delivers high accuracy and real-time insights.
While the initial focus is diabetes management, this versatile platform is well-positioned to expand to other biomarkers of chronic disease for future applications.
Our Mission
Transdermal Diagnostics’ mission is to transform the prevention, diagnosis, and management of chronic conditions through innovative, accessible, and sustainable technology.
The company is pioneering a needle-free, pain-free wearable platform that samples and quantifies target health biomarkers, and provides a more cost-effective, user-friendly and sustainable alternative to existing products.






Our Expert Team
A core group of highly specialised scientists and executives, each bringing extensive and unique expertise in MedTech and Life Sciences.



